Novel insulin derivatives

Details for Australian Patent Application No. 2004261353 (hide)

Owner Novo Nordisk A/S

Inventors Tagmose, Tina Moller; Hoeg-Jensen, Thomas; Ribel-Madsen, Ulla; Jonassen, Ib; Madsen, Peter; Havelund, Svend

Agent Shelston IP

Pub. Number AU-B-2004261353

PCT Pub. Number WO2005/012347

Priority 60/495,451 14.08.03 US; PA 2003 01129 05.08.03 DK

Filing date 22 July 2004

Wipo publication date 10 February 2005

Acceptance publication date 10 December 2009

International Classifications

A61K 38/28 (2006.01) Medicinal preparations containing peptides - Insulins

A61P 5/50 (2006.01) Drugs for disorders of the endocrine system

Event Publications

2 February 2006 PCT application entered the National Phase

  PCT publication WO2005/012347 Priority application(s): WO2005/012347

10 December 2009 Application Accepted

  Published as AU-B-2004261353

8 April 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004261356-Container

2004261347-Crate comprising multiple cavities